Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.

MLA

Leporrier, M., et al. “Randomized Comparison of Fludarabine, CAP, and ChOP in 938 Previously Untreated Stage B and C Chronic Lymphocytic Leukemia Patients.” Blood, vol. 98, no. 8, Oct. 2001, pp. 2319–25. EBSCOhost, https://doi.org/10.1182/blood.v98.8.2319.

APA

Leporrier, M., Chevret, S., Cazin, B., Boudjerra, N., Feugier, P., Desablens, B., Rapp, M. J., Jaubert, J., Autrand, C., Divine, M., Dreyfus, B., Maloum, K., Travade, P., Dighiero, G., Binet, J. L., & Chastang, C. (2001). Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood, 98(8), 2319–2325. https://doi.org/10.1182/blood.v98.8.2319

Chicago

Leporrier, M, S Chevret, B Cazin, N Boudjerra, P Feugier, B Desablens, M J Rapp, et al. 2001. “Randomized Comparison of Fludarabine, CAP, and ChOP in 938 Previously Untreated Stage B and C Chronic Lymphocytic Leukemia Patients.” Blood 98 (8): 2319–25. doi:10.1182/blood.v98.8.2319.